ÂÜÀòÂÒÂ×

Simon Brunner is a Senior Associate at Flagship Pioneering and Co-founder and Head of Platform at Quotient Therapeutics. Prior to their current roles, Simon was the Co-founder and CEO of a startup and held various data science positions at Boston Consulting Group (BCG) and BCG GAMMA. Simon also worked as a Postdoctoral Fellow in computational research in cancer genomics at Wellcome Trust Sanger Institute and as a Genomics Advisor at Medopad. Simon's educational background includes a PhD in Molecular, synthetic and computational biology from the University of Cambridge, as well as degrees in Synthetic Biology, Systems Biology, and Biochemistry from ETH Zürich and the University of California, Berkeley.